Skip to main content

Journey Medical Corp

DERM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867066

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Journey Medical Corp changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of DERM: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders3738+1
Shares3.79M5.02M+1.23M (+32.4%)
Value$14.8M$29.6M+$14.8M (+99.8%)

New holders (6)

Institutions that held Journey Medical Corp at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to DERM in Q1 2025
InstitutionSharesValue% of portfolio
Wasatch Advisors Inc930,603$5.49M0.03%
Opaleye Management Inc.69,323$409.0K0.09%
Pale Fire Capital SE27,274$160.9K0.02%
Millennium Management LLC21,473$126.7K0.00%
Jane Street Group, LLC18,599$109.7K0.00%
FMR LLC2$130.00%

Sold out (5)

Institutions that held Journey Medical Corp at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of DERM in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
ORG Wealth Partners, LLC20,871$81.6K
Dimensional Fund Advisors LP20,455$80.0K
Kestra Advisory Services, LLC15,000$58.6K
Nwam LLC10,620$41.5K
Tower Research Capital LLC (TRC)2,923$11.4K